ACR/ARHP 2018 Annual Meeting
Obesity Negatively Affects Treatment Response to JAK Inhibitors in RA
Patients treated with JAK inhibitors for rheumatoid arthritis may be less likely to have low disease activity if they are obese compared with those who are overweight.
